Mrs. Carol Therese Haughey, PA Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1050 Legion Drive, Elm Grove, WI 53122 Phone: 262-782-8272 Fax: 262-782-5420 |
News Archive
Spectrum Pharmaceuticals, a commercial-stage biotechnology company with a primary focus in oncology, today announced that it has met with the FDA regarding it's supplemental New Drug Application (sNDA) for FUSILEVĀ® (levoleucovorin) for injection for the treatment of patients with advanced metastatic colorectal cancer. In October 2009, the FDA issued a Complete Response letter regarding its sNDA for FUSILEV.
The research was part of the Platelet-Oriented Inhibition in New TIA and minor ischemic stroke trial - a randomized, double-blind, placebo-controlled trial conducted between May 2010 and December 2017.
Tigris Pharmaceuticals, Inc., today announced enrollment of its first patient in a randomized Phase 2 clinical trial of AFP-464 with or without Faslodex in estrogen receptor (ER)-positive breast cancer patients.
In Uganda the prescription of three antiretroviral (ARV) drugs, which aim to suppress the virus to prevent disease progression, have resulted in huge reductions in HIV mortality rates. However, disease is not the only scourge in Uganda, and a new study in The Journal of Clinical Pharmacology explores the impact food insecurity may have on treating pregnant women.
› Verified 6 days ago